Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Front Oncol ; 10: 283, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32292715

RESUMO

Bladder cancer (BC) is the ninth most common cancer worldwide, but molecular changes are still under study. During tumor progression, Epithelial cadherin (E-cadherin) expression is altered and ß-catenin may be translocated to the nucleus, where it acts as co-transcription factor of tumor invasion associated genes. This investigation further characterizes E-cadherin and ß-catenin associated changes in BC, by combining bioinformatics, an experimental murine cell model (MB49/MB49-I) and human BC samples. In in silico studies, a DisGeNET (gene-disease associations database) analysis identified CDH1 (E-cadherin gene) as one with highest score among 130 BC related-genes. COSMIC mutation analysis revealed CDH1 low mutations rates. Compared to MB49 control BC cells, MB49-I invasive cells showed decreased E-cadherin expression, E- to P-cadherin switch, higher ß-catenin nuclear signal and lower cytoplasmic p-Ser33-ß-catenin signal, higher Ephrin-B1 ligand and EphB2 receptor expression, higher Phospho-Stat3 and Urokinase-type Plasminogen Activator (UPA), and UPA receptor expression. MB49-I cells transfected with Ephrin-B1 siRNA showed lower migratory and invasive capacity than control cells (scramble siRNA). By immunohistochemistry, orthotopic MB49-I tumors had lower E-cadherin, increased nuclear ß-catenin, lower pSer33-ß-catenin cytoplasmic signal, and higher Ephrin-B1 expression than MB49 tumors. Similar changes were found in human BC tumors, and 83% of infiltrating tumors depicted a high Ephrin-B1 stain. An association between higher Ephrin-B1 expression and higher stage and tumor grade was found. No association was found between abnormal E-cadherin signal, Ephrin-B1 expression or clinical-pathological parameter. This study thoroughly analyzed E-cadherin and associated changes in BC, and reports Ephrin-B1 as a new marker of tumor aggressiveness.

2.
Urology ; 120: 244-247, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-29966602

RESUMO

OBJECTIVE: To review surgical outcomes in urinary undiversions and describe short and long-term complications. METHODS: Retrospective review of patients who underwent urinary undiversion in our institution between May 2010 and May 2016. Complications were graded according to the Clavien classification. All patients completed the Patient Global Impression of Improvement questionnaire to indicate overall satisfaction with urinary undiversion. RESULTS: Median time from the cystectomy to undiversion was 29 months (range 11-53 months). Five patients (55%) reported significant distress related to the ileal conduit and were undiverted into an orthotopic neobladder. A female patient with an orthotopic neobladder and severe urinary incontinence received neobladder neck closure and catheterizable channel. Another female patient with an orthotopic neobladder was undiverted into an Indiana Pouch. Complications during the first 60 days were mostly minor, Clavien I (1 patient), 5 patients Clavien II, and a patient with Clavien IIIb. Patient Global Impression of Improvement questionnaire scores showed that 6 patients (67%) felt "Very much better" and 3 patients (33%) felt "Much better" after urinary undiversion 60%. CONCLUSION: After urinary undiversions, minor complication rate is high, and major complication rate is considerable. Urinary undiversions are a highly complex, yet feasible procedure, which requires experienced multidisciplinary teams and demands appropriate patient selection. Patients, after undiversions show a high degree of satisfaction with long-term satisfactory outcomes, which points out the need for consideration for these procedures once the oncologic disease is controlled.


Assuntos
Bolsas Cólicas , Estruturas Criadas Cirurgicamente , Derivação Urinária/efeitos adversos , Idoso , Neoplasias do Colo/cirurgia , Cistectomia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias , Estudos Retrospectivos , Neoplasias da Bexiga Urinária/cirurgia , Incontinência Urinária/etiologia , Coletores de Urina , Neoplasias do Colo do Útero
3.
Rev. argent. urol. (1990) ; 83(4): 145-149, 2018. tab, ilus
Artigo em Espanhol | LILACS | ID: biblio-987929

RESUMO

Introducción: El estadío pT0 del cáncer de vejiga implica la ausencia de enfermedad en la pieza de cistectomía radical (CR). El objetivo de este estudio es describir los resultados oncológicos de los pacientes con estadío pT0 posterior a CR por carcinoma urotelial de vejiga. Materiales y métodos: Estudio retrospectivo de pacientes sometidos a CR por cáncer de vejiga, en una sola institución, sin neoadyuvancia, entre junio de 2005 y julio de 2013. Se incluyeron aquellos pacientes con diagnóstico histológico de estadío pT0 pN0. Se estimó la sobrevida global, sobrevida cáncer-específica y sobrevida libre de recidiva con el método de Kaplan-Meier. Resultados: De 254 pacientes cistectomizados, 17 presentaron estadío pT0 pN0 (6,7%). La mediana de edad fue 67 años (rango 49-85), 15 pacientes fueron hombres (88%). Los resultados patológicos posterior a resección transuretral de vejiga (RTUv) fueron 17% pT1 (n=3) y 83% pT2 (n=14). La mediana de tiempo entre RTUv y CR fue 60 días (rango 30- 95). Al 41% se le realizó derivación urinaria tipo Bricker y al 59%, una neovejiga. La mediana de estadía hospitalaria fue 8 días (rango 6-44). Se evidenció adenocarcinoma de próstata en 4 pacientes. La mediana de ganglios resecados fue 6 (rango 2-17). Ningún paciente recibió adyuvancia. La mediana de seguimiento fue 69 meses (rango 5-120). Un paciente presentó recidiva uretral a los 72 meses de la CR. La sobrevida cáncer-específica fue 100%, la sobrevida libre de recaída a 5 años fue 83,3% (intervalo de confianza [IC] de 95%: 53,5-100) y la sobrevida global a 5 años fue 82,4% (IC 95%: 64,7-100). Conclusión: El estadío pT0 del cáncer de vejiga presenta resultados oncológicos más favorables que los estadíos más avanzados. Sin embargo, la posibilidad de recurrencia existe, por lo que no se debe discontinuar el seguimiento de estos pacientes (AU)


Introduction: There are cases in which there is no evidence of disease in the radical cystectomy (RC) specimen (pT0 stage). The purpose of this study is to evaluate oncological outcomes of patients with pT0 bladder cancer after RC, in a single institution, without neo-adjuvant therapy. Materials and methods: Patients who underwent radical cystectomy from June 2005 to July 2013 were reviewed retrospectively. All patients had history of bladder urothelial carcinoma, treated with transurethral resection of the bladder (TURB) and confirmed with pathological analysis. Study variables included TURB pathology, time to RC, and pathologic features. Overall survival (OS), cancer-specific survival (CSS) and recurrence-free survival (RFS) were estimated. Results: RC was performed on 254 patients; 17 patients (6.7%) had pT0N0 stage. Median age was 67 years (range 49-85 years); 15 patients were male (88%). TURB pathology specimens were 17% pT1 (n=3), and 83% pT2 (n=14). Median time between TURB and RC was 60 days (range 30-95). Seven patients (41%) received an ileal conduit, and ten patients (59%) received a neobladder. Median hospital stay was eight days (range 6-44). Prostate adenocarcinoma was found in four (23%) patients. Median resected lymph nodes were six (range 2-17). No patients received adjuvant chemotherapy. Median follow-up was 69 months (range 5-120 months). One patient had a urethral relapse 72 months after RC. There was no cancer-specific mortality. RFS at 5 years was 83.3% (confidence interval [CI] 95%: 53.5-100); OS at 5 years was 82.4% (CI 95%: 64.7-100). Conclusion: pT0 stage after radical cystectomy shows more favorable oncologic outcomes than higher stages. However, cancer recurrence was found in a low number of patients, thus, patient follow-up should be maintained (AU)


Assuntos
Humanos , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Neoplasias da Bexiga Urinária/cirurgia , Carcinoma de Células de Transição/cirurgia , Cistectomia , Taxa de Sobrevida , Resultado do Tratamento , Neoplasias da Bexiga Urinária/patologia , Estudos Retrospectivos
4.
Can J Urol ; 24(4): 8932-8933, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28832314

RESUMO

Emphysematous cystitis is a rare type of urinary tract infection that is characterized by air pockets within the bladder wall and lumen, which come from gas that is mainly produced by gram-negative bacteria, notably Escherichia coli. This infection is more common in older women with poorly controlled diabetes. An abdominal computerized tomography (CT) scan is the gold standard method to make the diagnosis. The infection can be life-threatening, so prompt treatment is essential. We present a case of a 39-year-old woman with poorly controlled type 2 diabetes who developed emphysematous cystitis after a bilateral adrenalectomy. The infection was diagnosed by a CT scan that revealed gas in the bladder wall. A urine culture revealed 106 colonies/mL of Klebsiella pneumoniae. After a month of treatment with intravenous antibiotics (vancomycin plus meropenem plus colistin), bladder drainage, and strict glycemic control, the patient had a good outcome.


Assuntos
Cistite/microbiologia , Enfisema/microbiologia , Infecções por Klebsiella , Klebsiella pneumoniae , Adulto , Cistite/complicações , Enfisema/complicações , Feminino , Humanos
10.
Nexo rev. Hosp. Ital. B.Aires ; 23(2): 29-32, jun. 2003. ilus
Artigo em Espanhol | BINACIS | ID: bin-3092

RESUMO

La neuromodulación mediante estimulación eléctrica de las raíces sacras (EERS) es una alternativa terapéutica no destructiva y reversible, indicada en pacientes con disfunción miccional crónica cuando los tratamientos conservadores han resultado ineficaces o mal tolerados. Esta estimulación logra influir sobre el comportamiento de la vejiga, del esfínter uretral externo y de los músculos del suelo pélvico. La estimulación es de tipo eléctrico y se ejerce mediante salvas de pulsos de corriente aplicada a la tercera raíz sacra (S3). El objetivo primordial de esta técnica es restablecer el patrón de micción normal


Assuntos
Humanos , Masculino , Feminino , Transtornos Urinários/terapia , Terapia por Estimulação Elétrica , Incontinência Urinária/terapia , Região Sacrococcígea/inervação , Qualidade de Vida , Doença Crônica , Seleção de Pacientes
11.
Nexo rev. Hosp. Ital. B.Aires ; 23(2): 29-32, jun. 2003. ilus
Artigo em Espanhol | LILACS | ID: lil-391889

RESUMO

La neuromodulación mediante estimulación eléctrica de las raíces sacras (EERS) es una alternativa terapéutica no destructiva y reversible, indicada en pacientes con disfunción miccional crónica cuando los tratamientos conservadores han resultado ineficaces o mal tolerados. Esta estimulación logra influir sobre el comportamiento de la vejiga, del esfínter uretral externo y de los músculos del suelo pélvico. La estimulación es de tipo eléctrico y se ejerce mediante salvas de pulsos de corriente aplicada a la tercera raíz sacra (S3). El objetivo primordial de esta técnica es restablecer el patrón de micción normal


Assuntos
Humanos , Masculino , Feminino , Terapia por Estimulação Elétrica , Incontinência Urinária , Transtornos Urinários , Doença Crônica , Seleção de Pacientes , Qualidade de Vida , Região Sacrococcígea/inervação
12.
[Buenos Aires]; [Hospital Italiano de Buenos Aires]; s.f. CD-ROM, 5 min. 2 seg.
Não convencional em Espanhol | BINACIS | ID: biblio-1214905
14.
[Buenos Aires]; [Hospital Italiano de Buenos Aires]; s.f. CD-ROM, 12 min. 46 seg.
Não convencional em Espanhol | BINACIS | ID: biblio-1214938
15.
[Buenos Aires]; [Hospital Italiano de Buenos Aires]; s.f. 12 min. 46 seg. (111147).
Não convencional em Espanhol | BINACIS | ID: bin-111147
17.
[Buenos Aires]; [Hospital Italiano de Buenos Aires]; s.f. 5 min. 2 seg. (111114).
Não convencional em Espanhol | BINACIS | ID: bin-111114
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA